| |
| |
|
| Insider
Information: |
Susman Sally |
| Relationship: |
Executive Vice President |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
164,091 |
|
|
Indirect Shares
|
813 |
|
|
| Direct
Value |
$4,984,295 |
|
|
|
Indirect Value
|
$23,236 |
|
|
| Total
Shares |
164,904 |
|
|
| Total
Value |
$5,007,531 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -9.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Estee Lauder Companies Inc |
EL |
Exec.VP, Global Commun... |
2007-10-31 |
2,480 |
2004-12-03 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Executive Vice President |
2024-02-23 |
161,611 |
2024-02-23 |
813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2017-09-12 |
4 |
AS |
$35.00 |
$1,338,050 |
D/D |
(38,230) |
115,096 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-24 |
4 |
D |
$35.98 |
$2,113,328 |
D/D |
(58,509) |
148,463 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-24 |
4 |
OE |
$18.90 |
$1,736,456 |
D/D |
91,876 |
206,972 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-28 |
4 |
OE |
$27.37 |
$3,014,313 |
D/D |
110,132 |
245,362 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-28 |
4 |
D |
$35.70 |
$3,222,946 |
D/D |
(89,885) |
155,477 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-07-20 |
4 |
AS |
$37.13 |
$1,502,925 |
D/D |
(40,381) |
115,096 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
108,096 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
D |
$41.91 |
$2,668,210 |
D/D |
(62,853) |
142,980 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
OE |
$21.03 |
$2,055,409 |
D/D |
97,737 |
205,833 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$4,089,128 |
D/D |
(96,016) |
180,819 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
48,092 |
276,835 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$2,764,141 |
D/D |
85,763 |
228,743 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-03-04 |
4 |
AS |
$42.90 |
$377,444 |
D/D |
(8,725) |
172,094 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-03-04 |
4 |
AS |
$42.89 |
$2,760,698 |
D/D |
(63,998) |
108,096 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$2,623,675 |
D/D |
(72,253) |
131,088 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,783 |
203,341 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
OE |
$34.59 |
$2,506,530 |
D/D |
72,464 |
180,558 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$2,507,144 |
D/D |
(70,738) |
151,758 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
OE |
$27.37 |
$2,501,837 |
D/D |
91,408 |
222,496 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-11-09 |
4 |
AS |
$41.94 |
$1,831,184 |
D/D |
(43,662) |
108,096 |
0 |
% |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$2,355,800 |
D/D |
(68,188) |
121,575 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-25 |
4 |
OE |
$22.89 |
$1,869,358 |
D/D |
81,667 |
189,763 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$2,048,128 |
D/D |
(59,591) |
133,883 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-27 |
4 |
OE |
$22.35 |
$1,606,943 |
D/D |
71,899 |
193,474 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-11-26 |
4 |
S |
$54.43 |
$2,415,578 |
D/D |
(44,308) |
89,575 |
0 |
% |
|
95 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
